As of 2025-09-16, the EV/EBITDA ratio of Rapt Therapeutics Inc (RAPT) is -1.71. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAPT's latest enterprise value is 184.15 mil USD. RAPT's TTM EBITDA according to its financial statements is -107.73 mil USD. Dividing these 2 quantities gives us the above RAPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-09-15 | -1.71 |
| 2025-09-12 | -1.57 |
| 2025-09-11 | -1.50 |
| 2025-09-10 | -1.31 |
| 2025-09-09 | -1.25 |
| 2025-09-08 | -1.21 |
| 2025-09-05 | -1.17 |
| 2025-09-04 | -1.14 |
| 2025-09-03 | -0.97 |
| 2025-09-02 | -1.04 |
| 2025-08-29 | -0.98 |
| 2025-08-28 | -0.99 |
| 2025-08-27 | -1.01 |
| 2025-08-26 | -0.97 |
| 2025-08-25 | -0.92 |
| 2025-08-22 | -0.97 |
| 2025-08-21 | -0.90 |
| 2025-08-20 | -0.85 |
| 2025-08-19 | -0.91 |
| 2025-08-18 | -1.02 |
| 2025-08-15 | -1.03 |
| 2025-08-14 | -0.97 |
| 2025-08-13 | -0.89 |
| 2025-08-12 | -0.92 |
| 2025-08-11 | -0.76 |
| 2025-08-08 | -0.79 |
| 2025-08-07 | -0.85 |
| 2025-08-06 | -0.81 |
| 2025-08-05 | -0.83 |
| 2025-08-04 | -0.91 |
| 2025-08-01 | -0.88 |
| 2025-07-31 | -0.91 |
| 2025-07-30 | -0.98 |
| 2025-07-29 | -1.00 |
| 2025-07-28 | -1.14 |
| 2025-07-25 | -1.21 |
| 2025-07-24 | -1.14 |
| 2025-07-23 | -1.29 |
| 2025-07-22 | -1.09 |
| 2025-07-21 | -1.02 |
| 2025-07-18 | -1.02 |
| 2025-07-17 | -0.84 |
| 2025-07-16 | -0.88 |
| 2025-07-15 | -0.89 |
| 2025-07-14 | -0.66 |
| 2025-07-11 | -0.63 |
| 2025-07-10 | -0.65 |
| 2025-07-09 | -0.63 |
| 2025-07-08 | -0.58 |
| 2025-07-07 | -0.59 |